Pathogenesis of diabetic nephropathy: The role of oxidative stress and protein kinase C

Diabetes Research and Clinical Practice

Volumn 45, Issue 2-3, 1999, Pages 147-151

  Ha, Hunjoo ^a   Kim, Kyung Hwan ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Diabetic nephropathy; Extracellular matrix; High glucose; Oxidative stress; Protein kinase C

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; FIBRONECTIN; GLUCOSE; HYDROGEN PEROXIDE; LIPID PEROXIDE; PROTEIN KINASE C; TAURINE;

ARTICLE; AUTOOXIDATION; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GLUCOSE OXIDATION; HUMAN; HYPERGLYCEMIA; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEINURIA;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HUMANS; HYPERGLYCEMIA; KIDNEY GLOMERULUS; OXIDATIVE STRESS; PROTEIN KINASE C; RATS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0344548772     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00044-3     Document Type: Article

References (52)

1. Reichard P., Nilsson B.Y., Roseuqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. New Engl. J. Med. 329:1993;304-309.
2. The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus, New Engl. J. Med. 329 (1993) 977-986.
3. Stackhous S., Miller P.L., Park S.K., Meyer T.W. Reversal of glomerular hyperfiltration and renal hypertrophy by blood glucose normalization in diabetic rats. Diabetes. 39:1990;985-995.
4. Fukui M., Nakamura T., Ebihara I., Shirato I., Tomino Y., Koide H. ECM gene expression and its modulation by insulin in diabetic rats. Diabetes. 41:1992;1520-1527.
5. Han D.C., Kim Y.J., Cha M.K. et al. Glucose control suppressed the glomerular expression of TGF-β1 and the progression of experimental diabetic nephropathy (abstract). J. Am. Soc. Nephrol. 7:1996;1870.
6. Grønbaek H., Vogel I., Østerby R., Lancranjan I., Flyvbjerg A., Ørskov H. Effect of octreotide, captopril or insulin on renal change and UAE in long-term experimental diabetes. Kidney Int. 53:1998;173-180.
7. Greene D., Lattimer S.A., Sima A.A.F. Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications. New Engl. J. Med. 316:1987;599-606.
8. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl. J. Med. 318:1988;1315-1321.
9. Williamson J.R., Chang K., Frangos M. et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 42:1993;801-813.
10. King G.L., Ishii H., Koya D. Diabetic vascular dysfunctions: A model of excessive activation of protein kinase C. Kidney Int. 52(Suppl. 60):1997;S77-S85.
11. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
12. Sies H. Oxidative stress: Introduction. Sies H. Oxidative Stress; Oxidants and Antioxidants. 1991;xv-xxii Academic Press, London.
13. Baud L., Ardaillou L. Reactive oxygen species: Production and role in the kidney. Am. J. Physiol. 251:1986;F765-F776.
14. Shah S.V. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int. 35:1989;1093-1106.
15. Diamond J.R. The role of reactive oxygen metabolites in animal models of glomerular disease. Am. J. Kidney Dis. 19:1992;292-300.
16. Nath K.A., Fischereder M., Hostetter T.H. The role of oxidants in progressive renal injury. Kidney Int. 45(Suppl. 45):1994;S111-S115.
17. Nath K.A., Salahudeen A.K. Introduction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants. J. Clin. Invest. 86:1990;1179-1192.
18. Wolff S.P., Jiang Z.Y., Hunt J.V. Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radic. Biol. Med. 10:1991;339-352.
19. Wolff S.P. Diabetes mellitus and free radicals. Br. Med. Bull. 49:1993;642-652.
20. Larkins R.G., Dunlop M.E. The link between hyperglycemia and diabetic nephropathy. Diabetologia. 35:1992;499-504.
21. Haugarrd N. Cellular mechanisms of oxygen toxicity. Physiol. Rev. 48:1968;311-373.
22. Morgensen C.E. Natural history of renal function abnormalities in human diabetes mellitus: from normoalbuminuria to incipient and overt nephropathy. Brenner B.M., Stein J.H. The Kidney in Diabetes Mellitus. 1989;19-49 Churchill Livingstone, New York.
23. Ha H., Kim K.H. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int. 48(Suppl. 51):1995;S18-S21.
24. Asayama K., Yokota S., Kato K. Peroxisomal oxidases in various tissues of diabetic rats. Diabetes Res. Clin. Pract. 11:1991;89-94.
25. Parinandi N.L., Thompson E.W., Schmid H.H.O. Diabetic heart and kidney exhibit increased resistance to lipid peroxidation. Biochim. Biophys. Acta. 1047:1990;63-69.
26. Gutteridge J.M.C., Halliwell B. The measurement and mechanism of lipid peroxidation in biological system. Trends Biol. Sci. 15:1990;129-135.
27. Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9:1990;515-540.
28. Kasai H., Nishimura S., Kurokawa Y., Hayashi Y. Oral administration of the renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis. 8:1987;1959-1961.
29. Ha H., Kim C., Son Y., Chung M.H., Kim K.H. DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radic. Biol. Med. 16:1994;271-274.
30. Steffes M.W., Osterby R., Chavers B., Mauer S.M. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes. 38:1984;1077-1081.
31. Ayo S.H., Radnik R.A., Garoni J., Glass W.F. II, Kreisberg J.I. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am. J. Pathol. 136:1990;1339-1348.
32. Ayo S.H., Radnik R.A., Glass W.F. II et al. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high glucose medium. Am. J. Physiol. 260:1991;F185-F191.
33. Trachtman H., Futterweit S., Bienkowski R.S. Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 191:1993;759-765.
34. Trachtman H. Vitamin E prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Microvasc. Res. 47:1994;232-239.
35. Ha H., Lee S.H., Kim K.H. Effects of rebamipide in a model of experimental diabetes on the synthesis of transforming growth factor-β and fibronectin, and lipid peroxidation induced by high glucose in cultured mesangial cells. J. Pharmacol. Exp. Ther. 281:1997;1457-1462.
36. Ziyadeh F., Han D.C. Involvement of transforming growth factor-β and its receptors in the pathogenesis of diabetic nephropathy. Kidney Int. 52(Suppl. 60):1997;S7-S11.
37. Ha H., Kim K.H. Role of protein kinase C-mediated oxidative stress in increased TGF-β1 and fibronectin mRNAs in mesangial cells: Implications for diabetic nephropathy (abstract). Nephrology. 3(Suppl. 1):1997;A736.
38. Trachtman H., Futterweit S., Maesaka J. et al. Taurine ameliorates chronic streptozotocin-induced diabetic nephropathy in rats. Am. J. Physiol. 269:1995;F429-F438.
39. Koya D., Lee I.-K., Ishihi H., Kanoh H., King G.L. Prevention of glomerular dysfunction in diabetic rats by treatment of d-α-tocopherol. J. Am. Soc. Nephrol. 8:1997;426-435.
40. Craven P.A., DeRubertis F.R., Kagan V.E., Melhem M., Studer R.K. Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-β1, and glomerular size in diabetes. J. Am. Soc. Nephrol. 8:1997;1405-1411.
41. Ha H., Yu M.R., Kim K.H. Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free Radic. Biol. Med. 8:1999;944-950.
42. Craven P.A., DeRubertis F.R. Protein kinase C is activated in glomeruli from streptozocin diabetic rats: Possible mediation by glucose. J. Clin. Invest. 83:1989;1667-1675.
43. Craven P.A., Davidson C.M., DeRubertis F.R. Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis or glycerolipids. Diabetes. 39:1990;667-674.
44. Sah S.V. Light emission by isolated rat glomeruli in response to phorbol myristate acetate. J. Lab. Clin. Med. 98:1981;46-56.
45. Myanoshita A., Takahash T., Endou H. Inhibitory effect of cyclic AMP on phorbol-stimulated production of reactive oxygen metabolites in rat glomeruli. Biochem. Biophys. Res. Commun. 30:1989;519-525.
46. Ha H., Endou H. Lipid peroxidation in isolated rat nephron segments. Am. J. Physiol. 263:1992;F201-F207.
47. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes. 46(Suppl. 2):1997;S19-S25.
48. Lee H.B., Cha M.K., Song K.I. Pathogenic role of advanced glycosylation end products in diabetic nephropathy. Kidney Int. 52(Suppl. 60):1997;S60-S65.
49. Yan S.D., Schmidt A.M., Anderson G.M. Enhanced cellular oxidant stress by the interaction of advanced glycosylation end products with their receptors/binding proteins. J. Biol. Chem. 269:1994;9889-9897.
50. Wautier J.L., Chappeym O., Wautier M.P., Hori O., Stern D., Schmidt A.M. Receptor mediated endothelial dysfunction in diabetic vasculopathy: sRAGE blocks hyperpermeability. J. Clin. Invest. 97:1996;238-243.
51. Salahudeen A.K., Kanji V., Reckelhoff J.F., Schmidt A.M. Pathogenesis of diabetic nephropathy: a radical approach. Nephrol. Dial. Transplant. 12:1997;664-668.
52. Ha H., Kamanna V.S., Kirschenbaum M.A., Kim K.H. Role of glycated low density lipoprotein in mesangial extracellular matrix synthesis. Kidney Int. 52(Suppl. 60):1997;S54-S59.